These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1623227

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cholinergic treatment strategies in Alzheimer's disease].
    Kurz A, Rüster P, Romero B, Zimmer R.
    Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
    [No Abstract] [Full Text] [Related]

  • 3. Mechanism of action of cholinesterase inhibitors in Alzheimer's disease.
    Håkansson L.
    Acta Neurol Scand Suppl; 1993 Oct; 149():7-9. PubMed ID: 7907455
    [Abstract] [Full Text] [Related]

  • 4. Update on cholinergic enhancement therapy for Alzheimer disease.
    Read SL.
    Bull Clin Neurosci; 1987 Oct; 52():34-7. PubMed ID: 3334548
    [Abstract] [Full Text] [Related]

  • 5. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G.
    Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML.
    Pharmacotherapy; 1998 Oct; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [Abstract] [Full Text] [Related]

  • 10. [Neuroprotective therapy of Alzheimer's disease?].
    Mielke R.
    Dtsch Med Wochenschr; 1996 Nov 29; 121(48):1515. PubMed ID: 8983909
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacoepidemiology of tacrine in Alzheimer's disease.
    Begaud B, Haramburu F, Miremont G.
    Methods Find Exp Clin Pharmacol; 1996 Nov 29; 18 Suppl B():77-8. PubMed ID: 8899701
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
    García-López MT, Guardado-Santervás P.
    Rev Neurol; 1996 Nov 29; 32(4):394-7. PubMed ID: 11398762
    [No Abstract] [Full Text] [Related]

  • 15. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA.
    J Clin Psychiatry; 1998 Nov 29; 59 Suppl 9():28-32. PubMed ID: 9720484
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Advances in the treatment of Alzheimer's disease.
    Schneider LS.
    Aging (Milano); 1998 Apr 29; 10(2):156-7. PubMed ID: 9666210
    [No Abstract] [Full Text] [Related]

  • 18. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?].
    Drukarch B, Stoof JC.
    Ned Tijdschr Geneeskd; 1988 Oct 01; 132(40):1833-5. PubMed ID: 3185771
    [No Abstract] [Full Text] [Related]

  • 19. Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
    Volger BW.
    Clin Pharm; 1991 Jun 01; 10(6):447-56. PubMed ID: 2065522
    [Abstract] [Full Text] [Related]

  • 20. [Tacrine].
    Dávila C, Viteri C, de Castro P.
    Rev Med Univ Navarra; 1997 Jun 01; 41(1):58-64. PubMed ID: 9527715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.